QYSPA Trademark

Trademark Overview

On Friday, August 5, 2016, a trademark application was filed for QYSPA with the United States Patent and Trademark Office. The USPTO has given the QYSPA trademark a serial number of 87128560. The federal status of this trademark filing is REGISTERED as of Tuesday, May 5, 2020. This trademark is owned by Glaxo Group Limited. The QYSPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
qyspa

General Information

Serial Number87128560
Word MarkQYSPA
Filing DateFriday, August 5, 2016
Status700 - REGISTERED
Status DateTuesday, May 5, 2020
Registration Number6044803
Registration DateTuesday, May 5, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 29, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders
Translation of Words in MarkThe wording "QYSPA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStevenage SG12NY
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, October 31, 2016SUSPENSION LETTER WRITTEN
Tuesday, August 9, 2016NEW APPLICATION ENTERED
Tuesday, August 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 29, 2016ASSIGNED TO EXAMINER
Monday, October 31, 2016LETTER OF SUSPENSION E-MAILED
Monday, October 31, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, May 9, 2017ASSIGNED TO LIE
Tuesday, May 9, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, June 6, 2019SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, November 13, 2017REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, May 14, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 29, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, June 7, 2019SUSPENSION INQUIRY WRITTEN
Friday, June 7, 2019INQUIRY TO SUSPENSION E-MAILED
Friday, June 7, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, September 17, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, September 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 24, 2019ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, September 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 20, 2019ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, October 29, 2019PUBLISHED FOR OPPOSITION
Tuesday, October 29, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 9, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 4, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, March 4, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 4, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 4, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 9, 2020NOTICE OF ALLOWANCE CANCELLED
Tuesday, March 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 31, 20201(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, May 5, 2020REGISTERED-PRINCIPAL REGISTER
Monday, March 9, 2020TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 6, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 5, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 6, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 6, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 6, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 6, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

qyspa disorders treatment pharmaceutical preparations substances diseases system related immune dermatological